Wero is the new pan-European instant payment system rolling out across major EU banks from 2024 to 2026. It is designed to replace fragmented national payment rails (iDEAL in NL, Bancontact in BE, SEPA Direct in DE) with a unified European standard for instant consumer-flow payments. For research peptide buyers in the EU, Wero matters because it represents the future of payment infrastructure that suppliers will need to support to remain competitive.
What Wero actually is
Wero is built by the European Payments Initiative (EPI), a consortium of 14 major European banks and 2 payment service providers. It launched in mid-2024 in Germany, Belgium, and France, with the Netherlands integration following in 2025–2026. The technical foundation is SEPA Instant Credit Transfer (SCT Inst), giving 10-second settlement times pan-EU.
The differences from existing rails
| Feature | SEPA Standard | iDEAL | Wero |
|---|---|---|---|
| Settlement | 1–2 days | ~10 seconds | ~10 seconds |
| Coverage | EU-wide | NL only | EU-wide (rolling out) |
| Consumer flow | Bank transfer UX | Optimised bank-app | Optimised mobile-first |
| P2P + e-commerce | E-commerce only | E-commerce focus | Both natively |
| Account-to-account | Yes | Yes | Yes |
What Wero replaces (and doesn’t)
Wero is designed to compete with international card networks (Visa, Mastercard) and tech-platform payment systems (PayPal, Apple Pay, Google Pay) by offering a European-controlled alternative. It does NOT replace iDEAL immediately — iDEAL and Wero will coexist for years, with iDEAL eventually being absorbed into Wero infrastructure over 2025–2028.
Which banks support Wero today
Major banks across Germany, Belgium, France, and the Netherlands are rolling out Wero progressively:
- Germany: Deutsche Bank, Commerzbank, Sparkassen group, DKB
- Belgium: KBC, Belfius, BNP Paribas Fortis, ING Belgium
- France: BNP Paribas, Crédit Mutuel, Société Générale, La Banque Postale
- Netherlands: ING, Rabobank, ABN AMRO (rolling out)
Other EU countries (Spain, Italy, Portugal) are in pipeline for 2026–2027 integration.
Why Wero matters for research peptide buyers
- EU-wide instant payment — same speed and UX whether buying from a Dutch, German, or French supplier
- European data sovereignty — payments stay within European banking infrastructure, not routed through US card networks
- Lower transaction friction — fewer steps than SEPA, faster than card processing
- Native mobile flow — built mobile-first, matching how researchers actually order
- No card-data exposure — same security model as iDEAL
The Chempeptides position on Wero
Chempeptides operates EU-native and uses payment processors (Mollie, others) that are adding Wero support as banks roll out. For Dutch buyers, iDEAL remains the dominant option for the immediate term. As Wero penetrates the Dutch banking ecosystem in 2025–2026, native Wero checkout will become an additional option on Chempeptides without changing the existing iDEAL flow.
What changes for the buyer when Wero arrives
Practically, very little:
- Checkout page shows “Wero” as an additional payment option alongside iDEAL
- Same flow: select bank, authorise via bank app, instant confirmation
- Same settlement speed (10 seconds vs iDEAL’s similar window)
- The advantage shows when buying from suppliers in OTHER EU countries — Wero gives Dutch buyers the same instant flow with German or French suppliers
The longer-term EU payment landscape
2024 marks the year European banks took back consumer payment infrastructure from US card networks. Wero is the consumer-facing layer of that effort. For research peptide buyers within the EU, this is positive — payment friction reduces, settlement speeds increase, and supplier infrastructure consolidates around standards that work across all member states.
For now: iDEAL stays dominant
For Dutch buyers today, iDEAL is still the right answer for most orders. Wero adds future-proofing without replacing what works. See our iDEAL guide and the broader payment method comparison.
Browse the research catalogue or check out all supported payment methods on Chempeptides.
For laboratory research use only.